CIK 0001535955 · Non-accelerated filer<br>Smaller reporting company
Lipocine Inc.
Sign in to watch- Ticker
- LPCN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990370688
- Phone
- 801 994 7383
- Business address
- 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, United States, 84108
- Former names
- MARATHON BAR CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 220,000 shares at $0.32 ($69,542)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and President bought 40,000 shares at $0.38 ($15,340)
- 4 Open-market buy President and CEO bought 25,000 shares at $0.40 ($9,975)
- 4 Open-market sale EVP and Chief Financial Office sold 17,250 shares at $0.41 ($7,076)
- 4 Open-market sale CEO and President sold 43,500 shares at $0.41 ($17,835)
- 4 Open-market buy President and CEO bought 25,000 shares at an average $0.43 ($10,696)
- 4 Open-market buy CEO and President bought 50,000 shares at an average $0.40 ($20,095)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 9 · 175 filings